Lower-Dose Exemestane Regimens are Successful in Postmenopausal Patients With Stage 0 to II ER-Positive Breast Cancer.

Published Date: 17 Apr 2023

25 mg of exemestane three times per week is noninferior to the, according to research published in JAMA Oncology, based on results from a phase IIb trial.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Does pollution cause cancer?

2.

AI is equally capable of reading breast cancer scans as human radiologists.

3.

EVP Beats Cisplatin for Resectable MIBC

4.

New research points out a promising strategy for treating metastatic medulloblastoma

5.

Academics + Pharma = Big Bucks; New CAR-T Warnings; Patients Seek Cancer Tests.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot